Literature DB >> 4799556

Radioimmunoassay for measurement of gentamicin in blood.

W A Mahon, J Ezer, T W Wilson.   

Abstract

Gentamicin toxicity has been shown to be related to high concentrations in serum. Because there is a narrow range between its therapeutic and toxic levels, serial monitoring of gentamicin is the most reliable method of guiding therapy. Microbiological assays commonly in use do not afford the desired speed and accuracy, and results may be difficult to interpret in the presence of other antimicrobials. Hence, a rapid, sensitive, and highly specific radioimmunoassay for measurement of gentamicin in serum has been developed. Antibody to gentamicin was raised in rabbits by using a gentamicin-albumin conjugate. Tritiated gentamicin (specific activity 1.0 Ci/mM) competes with unlabeled gentamicin for binding sites on the antibody. Dextran-coated charcoal separates the unbound from antibody-bound gentamicin. Serum levels of gentamicin are determined by comparison with a standard curve. This method can detect concentrations as low as 0.01 mug/ml. Results of a 24-tube run can be obtained in 1 h, thus allowing modification of gentamicin dosage to advantage.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4799556      PMCID: PMC444462          DOI: 10.1128/AAC.3.5.585

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  12 in total

1.  GENTAMICIN SULFATE, NEW ANTIBIOTIC AGAINST GRAM-NEGATIVE BACILLI. LABORATORY, PHARMACOLOGICAL, AND CLINICAL EVALUATION.

Authors:  R L JAO; G G JACKSON
Journal:  JAMA       Date:  1964-09-14       Impact factor: 56.272

2.  Dose of gentamicin in patients with normal renal function and renal impairment.

Authors:  J C Gingell; P M Waterworth
Journal:  Br Med J       Date:  1968-04-06

3.  A rapid chemical assay for gentamicin.

Authors:  D H Smith; B Van Otto; A L Smith
Journal:  N Engl J Med       Date:  1972-03-16       Impact factor: 91.245

4.  Radioimmunoassay of an antibiotic: gentamicin.

Authors:  J E Lewis; J C Nelson; H A Elder
Journal:  Nat New Biol       Date:  1972-10-18

5.  Correlation of serum creatinine concentration and gentamicin half-life.

Authors:  R E Cutler; A M Gyselynck; W P Fleet; A W Forrey
Journal:  JAMA       Date:  1972-02-21       Impact factor: 56.272

6.  Ototoxicity of gentamicin in man: a survey and controlled analysis of clinical experience in the United States.

Authors:  G G Jackson; G Arcieri
Journal:  J Infect Dis       Date:  1971-12       Impact factor: 5.226

7.  Pharmacology of gentamicin in man.

Authors:  L J Riff; G G Jackson
Journal:  J Infect Dis       Date:  1971-12       Impact factor: 5.226

8.  Gentamicin therapy in renal failure: a nomogram for dosage.

Authors:  R A Chan; E J Benner; P D Hoeprich
Journal:  Ann Intern Med       Date:  1972-05       Impact factor: 25.391

9.  Relation between dose and levels of gentamicin in blood.

Authors:  R E Winters; K D Litwack; W L Hewitt
Journal:  J Infect Dis       Date:  1971-12       Impact factor: 5.226

10.  Gentamicin dosages for renal insufficiency. Adjustments based on endogenous creatinine clearance and serum creatinine concentration.

Authors:  M C McHenry; T L Gavan; R W Gifford; N A Geurkink; R A Van Ommen; M A Town; J G Wagner
Journal:  Ann Intern Med       Date:  1971-02       Impact factor: 25.391

View more
  18 in total

1.  Comparison of a radioimmunoassay with an enzymatic assay for gentamicin.

Authors:  B H Minshew; R K Holmes; C R Baxter
Journal:  Antimicrob Agents Chemother       Date:  1975-01       Impact factor: 5.191

2.  Comparison of enzymatic and microbiological gentamicin assays.

Authors:  A L Smith; J A Waitz; D H Smith; E M Oden; B B Emerson
Journal:  Antimicrob Agents Chemother       Date:  1974-09       Impact factor: 5.191

3.  Effects of divalent cations on binding of aminoglycoside antibiotics to human serum proteins and to bacteria.

Authors:  C H Ramirez-Ronda; R K Holmes; J P Sanford
Journal:  Antimicrob Agents Chemother       Date:  1975-03       Impact factor: 5.191

4.  Estimation of serum gentamicin by quenching fluoroimmunoassay.

Authors:  E J Shaw; R A Watson; J Landon; D S Smith
Journal:  J Clin Pathol       Date:  1977-06       Impact factor: 3.411

5.  Evaluation of the Bactec serum gentamicin assay.

Authors:  J P Manos; P F Jacobs
Journal:  Antimicrob Agents Chemother       Date:  1979-11       Impact factor: 5.191

6.  Hemagglutination inhibition assay for gentamicin.

Authors:  W A Mahon; R I Feldman; G H Scherr
Journal:  Antimicrob Agents Chemother       Date:  1977-02       Impact factor: 5.191

7.  Quantitation of antibiotics using high-pressure liquid chromatography: tetracycline.

Authors:  I Nilsson-Ehle; T T Yoshikawa; M C Schotz; L B Guze
Journal:  Antimicrob Agents Chemother       Date:  1976-05       Impact factor: 5.191

Review 8.  Drug interferences with plasma assays in therapeutic drug monitoring.

Authors:  S Yosselson-Superstine
Journal:  Clin Pharmacokinet       Date:  1984 Jan-Feb       Impact factor: 6.447

9.  Comparison of different tobramycin assays.

Authors:  E E Stobberingh; A W Houben; C P van Boven
Journal:  J Clin Microbiol       Date:  1982-05       Impact factor: 5.948

Review 10.  Why monitor serum levels of gentamicin?

Authors:  M Barza; M Lauermann
Journal:  Clin Pharmacokinet       Date:  1978 May-Jun       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.